diseas
one
worst
pandem
sweep
globe
recent
time
noteworthi
diseas
greatest
impact
elderli
herein
investig
potenti
childhood
vaccin
specif
measl
mump
rubella
mmr
identifi
could
potenti
confer
acquir
protect
identifi
sequenc
homolog
fusion
protein
measl
mump
virus
moreov
also
identifi
amino
acid
sequenc
homolog
macro
phosphatas
domain
rubella
viru
rubella
macro
domain
surfaceexpos
conserv
residu
present
attenu
rubella
viru
mmr
henc
hypothes
mmr
could
protect
poor
outcom
infect
initi
test
hypothesi
identifi
age
group
like
lack
mmr
vaccineinduc
immun
poorest
outcom
diseas
burden
correl
rubella
antibodi
titr
potenti
induc
homolog
sequenc
therefor
propos
vaccin
risk
age
group
mmr
vaccin
merit
consider
time
appropri
safe
intervent
race
discov
vaccin
slow
evolv
wave
coronaviru
diseas
crucial
aspect
establish
control
propos
one
world
worst
pandem
ferguson
et
al
rate
infect
escal
number
death
continu
rise
intervent
decreas
spread
viru
provid
immun
reduc
sever
diseas
peopl
develop
potenti
lifethreaten
symptom
come
earli
enough
strike
featur
disproportion
impact
elderli
popul
yet
paediatr
popul
mani
report
escap
mild
symptom
ferguson
et
al
peculiar
viral
ill
one
would
assum
collect
immun
accumul
lifetim
would
arm
elderli
popul
better
defenc
progeni
studi
center
diseas
control
prevent
cdc
found
children
like
peopl
older
least
like
get
sick
influenza
median
incid
valu
attack
rate
age
group
children
year
adult
year
adult
year
older
tokar
et
al
simpl
answer
differ
could
elderli
popul
physiolog
reserv
regener
capac
fight
sever
burden
diseas
howev
intriguingli
vaccin
histori
individu
patient
might
contribut
sever
diseas
tripl
vaccin
contain
attenu
measl
mump
rubella
mmr
virus
introduc
earli
ministri
health
nz
driven
larg
pandem
virus
individu
vaccin
made
avail
late
hamborski
et
al
case
rubella
pandem
origin
europ
spread
unit
state
lead
estim
million
case
caus
signific
disabl
foetu
pregnant
mother
result
blind
deaf
death
ministri
health
nz
current
mmr
vaccin
given
two
dose
offer
children
month
initi
second
dose
month
year
age
world
health
organis
vaccin
suffer
reduc
uptak
result
falsifi
claim
link
autism
editor
lancet
howev
wide
differ
nation
health
system
subregion
year
formal
introduc
vaccin
childhood
vaccin
schedul
establish
nation
campaign
promot
specif
vaccin
vulner
popul
hamborski
et
al
world
health
organis
recent
preprint
public
suggest
link
bacillu
bcg
vaccin
possibl
acquir
nonspecif
immun
miller
et
al
whilst
accept
bcg
vaccin
potenti
provid
nonspecif
immun
note
vaccin
statist
countri
bcg
would
similar
mmr
programm
provid
three
preliminari
line
evid
support
hypothesi
mmr
vaccin
may
provid
protect
sequenc
homolog
search
deltablast
search
follow
iter
psiblast
search
paramyxoviru
sequenc
use
queri
homolog
model
postfus
structur
base
postfus
structur
wall
et
al
construct
ass
overal
similar
fold
homolog
model
measl
viru
f
base
postfus
structur
human
parainfluenza
viru
f
yin
et
al
iter
psiblast
search
rubiviru
sequenc
queri
perform
crystal
structur
adrp
bound
adpribos
protein
data
bank
id
use
gener
homolog
model
rubella
viru
adrp
overal
fold
itali
spain
germani
three
european
countri
highest
number
report
case
moment
histor
vaccin
schedul
recommend
countri
identifi
relev
bodi
literatur
vaccin
schedul
spain
stiko
germani
filia
averag
coverag
age
group
calcul
use
unicef
coverag
estim
world
health
organis
ageadjust
casefat
risk
calcul
separ
male
femal
percentag
done
use
data
number
report
case
confirm
demographi
known
fatal
amongst
obtain
nation
report
state
region
confer
itali
istituto
superior
di
european
centr
diseas
prevent
control
ecdc
european
centr
diseas
serum
sampl
collect
anonymis
patient
admit
luton
dunstabl
univers
hospit
protocol
rec
approv
nh
health
research
author
case
stratifi
group
base
sever
moder
sever
includ
patient
admit
hospit
receiv
level
care
ward
base
high
sever
categori
includ
patient
requir
level
care
ituhdu
rubella
igg
level
measur
use
rub
igg
rbg
assay
biomerieux
lyon
franc
given
known
similar
glycoprotein
fold
paramyxovirus
coronavirus
wall
et
al
undertook
amino
acid
sequenc
homolog
search
measl
mump
virus
well
rubella
third
compon
mmr
vaccin
intriguingli
identifi
homolog
domain
sever
acut
respiratori
syndrom
coronaviru
caus
viru
rubella
viru
well
two
paramyxovirus
homolog
sequenc
rubella
align
psiblast
altschul
et
al
expect
valu
encod
macro
domain
nonstructur
protein
papainlik
proteas
rubella
viru
proteasemethyltransferas
macro
domain
bind
phosphat
nad
metabolit
phosphatas
adrp
activ
presenc
macro
domain
adrp
activ
coronavirus
paramyxovirus
alphavirus
note
previous
snijder
et
al
saikatendu
et
al
eriksson
et
al
crystal
structur
macro
domain
bound
adpribos
protein
data
bank
entri
allow
substrat
bind
pocket
catalyt
residu
identifi
analog
macro
domain
macro
domain
rubella
viru
share
amino
acid
sequenc
ident
suggest
protein
fold
gener
atom
model
rubella
viru
macro
domain
thread
rubella
sequenc
onto
macro
structur
guid
secondari
structur
predict
kelley
et
al
confid
score
fig
residu
conserv
rubella
macro
domain
includ
surfaceexpos
residu
residu
requir
adpribos
bind
adrp
enzymat
activ
coronavirus
fig
notabl
adrp
activ
requir
mous
coronaviru
mous
hepat
viru
caus
acut
hepat
mutat
singl
residu
macro
domain
abrog
adrp
activ
eriksson
et
al
residu
conserv
macro
domain
rubella
togeth
observ
suggest
adrp
activ
could
import
rubella
pathogenesi
macro
domain
present
attenu
rubella
viru
use
mmr
vaccin
although
within
cytoplasm
nonstructur
protein
could
contribut
vaccin
antigen
releas
upon
cell
lysi
display
via
mhci
vaccin
patient
henc
hypothesis
potenti
immunogen
element
macro
domain
conserv
rubella
viru
could
serv
target
bor
tcell
respons
patient
rubella
receiv
version
vaccin
regard
note
certain
antibodi
rais
surfac
glycoprotein
sarscov
crossneutr
wang
et
al
lv
et
al
wall
et
al
remain
unclear
extent
nonneutr
antibodi
crossreact
may
lead
antibodydepend
enhanc
lv
et
al
viral
envelop
glycoprotein
catalys
essenti
step
cell
entri
fusion
viral
cellular
membran
coronaviru
spike
glycoprotein
class
viral
membran
fusion
protein
share
trimer
ahel
coiledcoil
architectur
class
fusogen
includ
orthoand
paramyxovirus
wall
et
al
skehel
et
al
structur
homolog
search
dali
holm
et
al
molecular
model
kelley
et
al
confirm
clear
structur
homolog
spike
paramyxoviru
f
protein
includ
measl
measl
f
postfus
conform
dali
zscore
fig
homolog
sequenc
measl
align
psiblast
altschul
et
al
expect
valu
sequenc
ident
acid
region
fig
extens
set
surfaceexpos
residu
conserv
measl
f
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
mmr
vaccin
provid
protect
structur
biolog
suggest
one
would
predict
correl
mmr
vaccin
coverag
age
sex
associ
diseas
profil
test
predict
examin
data
itali
spain
germani
three
european
countri
highest
number
report
case
present
histor
vaccin
schedul
recommend
countri
identifi
relev
bodi
literatur
vaccin
schedul
spain
stiko
germani
filia
estim
averag
nation
immunis
coverag
measlescontain
vaccin
studi
countri
rang
within
germani
spain
itali
itali
rubellacontain
vaccin
rang
measlescontain
vaccin
itali
spain
germani
ageadjust
casefat
risk
relat
diseas
increas
age
countri
rang
within
among
femal
among
male
germani
spain
itali
respect
male
age
group
casefat
risk
start
germani
spain
itali
respect
femal
age
group
itali
spain
germani
fig
recognis
data
stage
preliminari
number
limit
includ
analysi
base
ecolog
rather
patientlevel
data
lack
reliabl
data
vaccin
coverag
differ
way
count
fatal
peopl
live
resid
count
countri
furthermor
differ
test
condit
mild
suspect
case
spain
itali
recommend
stay
home
test
mass
test
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
countri
studi
nevertheless
older
popul
male
like
die
less
like
seroposit
rubella
specif
immun
base
histor
vaccin
programm
three
countri
consid
studi
order
conclud
whether
mmr
vaccin
improv
outcom
infect
studi
use
individu
base
data
compar
mmr
immun
statu
affect
popul
warrant
predict
hypothesi
specif
rise
rubella
immunoglobulin
g
igg
titr
patient
correl
diseas
burden
marker
immunogen
kim
et
al
test
serum
sampl
collect
patient
admit
luton
dunstabl
hospit
univers
hospit
rec
stratifi
group
base
sever
moder
sever
includ
patient
admit
hospit
receiv
level
care
ward
base
high
sever
categori
includ
patient
requir
level
care
ituhdu
patient
high
sever
ill
averag
increas
level
rubella
igg
iuml
compar
patient
moder
sever
diseas
iuml
fig
comparison
immunoglobulin
igm
level
iuml
sever
diseas
iuml
moder
diseas
whilst
accept
possibl
trend
could
repres
preinfect
protect
rubella
infect
possibl
determin
studi
women
child
bear
age
igg
level
noninfect
patient
measur
iuml
suggest
unlik
develop
sever
symptom
diseas
igg
level
far
excess
prior
infect
seker
et
al
test
specif
antibodi
respons
exclud
possibl
infect
drive
nonspecif
antibodi
respons
test
six
patient
sever
moder
categori
highest
igg
titr
perform
elisa
varicella
zoster
viru
epitop
patient
return
posit
sampl
rang
ab
index
report
literatur
respons
vzv
vaccin
around
ab
index
smithnorowitz
et
al
consist
hypothesi
patient
specif
respond
identifi
homolog
rubella
primari
infect
high
level
igm
observ
within
day
diseas
onset
follow
later
product
igg
within
day
moder
level
alcon
et
al
blacksel
et
al
guzman
kouri
koraka
et
al
hamkar
et
al
secondari
infect
igm
detect
day
later
lower
level
primari
infect
igg
rapidli
increas
high
level
guzman
kouri
koraka
et
al
hamkar
et
al
appear
resembl
similar
pattern
data
even
high
titr
igg
igm
level
bare
rais
case
seri
high
titr
discov
patient
admit
period
less
day
mind
suggest
igg
titter
trend
diseas
burden
basi
share
homolog
rubella
viru
one
propos
would
viral
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
load
respons
diseas
sever
drive
high
antibodi
respons
equal
howev
dv
presenc
higher
concentr
antibodi
could
exacerb
diseas
burden
antibodi
neutralis
natur
halstead
increas
sever
secondari
infect
believ
result
least
partial
antibodydepend
enhanc
ade
dv
infect
engag
antibodyviru
immun
complex
facilit
viru
entri
suscept
myeloid
cell
type
halstead
et
al
interestingli
balsiti
et
al
demonstr
even
antibodi
level
neutralis
vitro
crossreact
polyclon
monoclon
antibodi
enhanc
diseas
vivo
howev
also
report
complet
elimin
viraemia
highdos
serotypespecif
antibodi
thu
hypothesis
administr
normal
human
immunoglobulin
nhig
contain
antibodi
three
virus
would
potenti
rescu
sever
infect
administ
time
fashion
taken
togeth
preliminari
data
would
support
hypothesi
rubella
vaccin
could
provid
protect
poor
outcom
infect
determin
potenti
effect
mmr
vaccin
would
necessari
know
vaccin
statu
younger
patient
infect
sever
diseas
link
propos
vaccin
risk
age
group
mmr
vaccin
consid
timeappropri
safe
intervent
creat
vaccin
arduou
may
requir
time
simpli
afford
meanwhil
help
could
immedi
avail
greatest
need
spike
glycoprotein
class
viral
membran
fusion
protein
share
structur
similar
fusion
protein
measl
mump
virus
macro
domain
rubella
viru
share
amino
acid
sequenc
ident
interestingli
residu
conserv
rubella
macro
domain
includ
surfaceexpos
residu
present
attenu
rubella
viru
use
mmr
vaccin
identifi
popul
level
older
popul
male
like
die
less
like
seroposit
rubellaspecif
immun
base
histor
vaccin
programm
three
countri
consid
report
final
hypothesi
macro
domain
could
recognis
antibodi
rais
rubella
support
data
demonstr
patient
infect
rais
level
rubella
igg
level
keep
secondari
rubella
infect
taken
togeth
suggest
mmr
prevent
infect
could
potenti
reduc
poor
outcom
conclud
whether
mmr
vaccin
improv
outcom
infect
studi
use
individu
base
data
compar
mmr
immun
statu
affect
popul
warrant
view
opinion
author
express
herein
necessarili
state
reflect
ecdc
accuraci
author
statist
analysi
find
report
respons
ecdc
ecdc
respons
conclus
opinion
drawn
data
provid
ecdc
respons
correct
data
data
manag
data
merg
data
collat
provis
data
ecdc
shall
held
liabl
improp
incorrect
use
data
conserv
residu
includ
surfaceexpos
residu
residu
involv
adpribos
phosphatas
adrp
catalysi
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
figur
measl
rubella
vaccin
coverag
agespecif
casefat
risk
age
group
sex
spain
b
itali
c
germani
shade
background
repres
rubella
vaccin
target
femal
popul
green
mmr
vaccin
target
male
femal
popul
orang
base
histor
nation
vaccin
schedul
compulsori
recommend
vaccin
specif
nation
vaccin
campaign
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
figur
rubella
igg
titr
uiml
measur
posit
patient
patient
stratifi
high
moder
sever
group
base
level
hospit
care
requir
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
